Follow
Sudarshan Paramsothy
Sudarshan Paramsothy
Clinical Senior Lecturer, University of Sydney (Concord Clinical School)
Verified email at sydney.edu.au
Title
Cited by
Cited by
Year
Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial
S Paramsothy, MA Kamm, NO Kaakoush, AJ Walsh, J van den Bogaerde, ...
The Lancet 389 (10075), 1218-1228, 2017
11572017
Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta-analysis
S Paramsothy, R Paramsothy, DT Rubin, MA Kamm, NO Kaakoush, ...
Journal of Crohn's and Colitis 11 (10), 1180-1199, 2017
4392017
Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis
S Paramsothy, S Nielsen, MA Kamm, NP Deshpande, JJ Faith, ...
Gastroenterology 156 (5), 1440-1454. e2, 2019
3682019
Fecal microbiota transplantation: indications, methods, evidence, and future directions
TJ Borody, S Paramsothy, G Agrawal
Current gastroenterology reports 15, 1-7, 2013
3392013
Fecal microbiota transplantation: indications, methods, evidence, and future directions
TJ Borody, S Paramsothy, G Agrawal
Current gastroenterology reports 15, 1-7, 2013
3392013
Therapeutic faecal microbiota transplantation: current status and future developments
TJ Borody, LJ Brandt, S Paramsothy
Current opinion in gastroenterology 30 (1), 97-105, 2014
1932014
Donor recruitment for fecal microbiota transplantation
S Paramsothy, TJ Borody, E Lin, S Finlayson, AJ Walsh, D Samuel, ...
Inflammatory bowel diseases 21 (7), 1600-1606, 2015
1642015
Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial
C Haifer, S Paramsothy, NO Kaakoush, A Saikal, S Ghaly, T Yang, ...
The lancet Gastroenterology & hepatology 7 (2), 141-151, 2022
1262022
Fungal trans-kingdom dynamics linked to responsiveness to fecal microbiota transplantation (FMT) therapy in ulcerative colitis
I Leonardi, S Paramsothy, I Doron, A Semon, NO Kaakoush, JC Clemente, ...
Cell host & microbe 27 (5), 823-829. e3, 2020
1252020
The current state of the art for biological therapies and new small molecules in inflammatory bowel disease
S Paramsothy, AK Rosenstein, S Mehandru, JF Colombel
Mucosal immunology 11 (6), 1558-1570, 2018
1072018
Defined microbiota transplant restores Th17/RORγt+ regulatory T cell balance in mice colonized with inflammatory bowel disease microbiotas
GJ Britton, EJ Contijoch, MP Spindler, V Aggarwala, B Dogan, G Bongers, ...
Proceedings of the National Academy of Sciences 117 (35), 21536-21545, 2020
722020
Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice
C Haifer, CR Kelly, S Paramsothy, D Andresen, LE Papanicolas, ...
Gut 69 (5), 801-810, 2020
702020
acute severe ulcerative colitis–evidence‐based consensus statements
JH Chen, JM Andrews, V Kariyawasam, N Moran, P Gounder, G Collins, ...
Alimentary pharmacology & therapeutics 44 (2), 127-144, 2016
702016
Epidemiology of inflammatory bowel disease in South America: A systematic review
S Selvaratnam, S Gullino, L Shim, E Lee, A Lee, S Paramsothy, ...
World Journal of Gastroenterology 25 (47), 6866, 2019
582019
Superior treatment persistence with ustekinumab in Crohn’s disease and vedolizumab in ulcerative colitis compared with anti‐TNF biological agents: real‐world registry data from …
Y Ko, S Paramsothy, Y Yau, RW Leong
Alimentary Pharmacology & Therapeutics 54 (3), 292-301, 2021
462021
Gastroenterologist perceptions of faecal microbiota transplantation
S Paramsothy, AJ Walsh, T Borody, D Samuel, J Van Den Bogaerde, ...
World Journal of Gastroenterology: WJG 21 (38), 10907, 2015
422015
Use of medications during pregnancy and breastfeeding for Crohn’s disease and ulcerative colitis
R Laube, S Paramsothy, RW Leong
Expert Opinion on Drug Safety 20 (3), 275-292, 2021
362021
Safety of drugs used for the treatment of Crohn’s disease
A Pudipeddi, V Kariyawasam, C Haifer, B Baraty, S Paramsothy, ...
Expert Opinion on Drug Safety 18 (5), 357-367, 2019
332019
An update on fecal microbiota transplantation for the treatment of gastrointestinal diseases
KMJ Waller, RW Leong, S Paramsothy
Journal of gastroenterology and hepatology 37 (2), 246-255, 2022
322022
Multi donor intense faecal microbiota transplantation is an effective treatment for resistant ulcerative colitis: A randomised placebocontrolled trial and microbiota analysis
N Kaakoush, J Van Den Bogaerde, S Paramsothy, R Paramsothy, W Ng, ...
Journal of Gastroenterology and Hepatology (Australia), 2016
322016
The system can't perform the operation now. Try again later.
Articles 1–20